According to the SEC Form 4 filings, Talton Sheila, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $25,228 | 1 | 100 |
| 2025-12-05 | Butterfly Network, Inc. BFLY | 200,000 0.0791% | $3.06 | $611,300 | +0.11% | |||
| 2025-12-05 | Biglari Holdings Inc. BH | Chairman and CEO | 1,465 0.0475% | $306.90 | $449,609 | -0.51% | ||
| 2025-12-05 | Sale | Cytokinetics, Incorporated CYTK | EVP, Chief Commercial Officer | 52,486 0.0443% | $65.95 | $3.46M | -0.42% | |
| 2025-12-05 | Sale | DocuSign, Inc. DOCU | director | 363 0.0002% | $64.50 | $23,414 | +1.81% | |
| 2025-12-05 | Sale | Dominari Holdings Inc. DOMH | COO | 140,000 0.8589% | $3.82 | $534,254 | +1.94% | |
| 2025-12-05 | Sale | Dynatrace, Inc. DT | director | 253 <0.0001% | $44.24 | $11,193 | +0.43% | |
| 2025-12-05 | Sale | Dyne Therapeutics, Inc. DYN | Chief Medical Officer | 880 0.0006% | $20.72 | $18,234 | -2.12% | |
| 2025-12-05 | Sale | Dyne Therapeutics, Inc. DYN | Chief Commercial Officer | 144 0.0001% | $20.72 | $2,984 | -2.12% | |
| 2025-12-05 | Sale | Dyne Therapeutics, Inc. DYN | CEO & President | 2,662 0.0019% | $20.72 | $55,157 | -2.12% | |
| 2025-12-05 | Sale | Enanta Pharmaceuticals, Inc. ENTA | See Remarks | 323 0.0015% | $14.23 | $4,596 | +2.6% | |
| 2025-12-05 | Sale | Enanta Pharmaceuticals, Inc. ENTA | See Remarks | 542 0.0025% | $14.23 | $7,713 | +2.6% | |
| 2025-12-05 | Sale | Enanta Pharmaceuticals, Inc. ENTA | Chief Medical Officer | 798 0.0036% | $14.23 | $11,356 | +2.6% | |
| 2025-12-05 | Sale | Enanta Pharmaceuticals, Inc. ENTA | Chief Product Strategy Officer | 2,106 0.0096% | $14.23 | $29,968 | +2.6% | |
| 2025-12-05 | Sale | Enanta Pharmaceuticals, Inc. ENTA | Chief Business Officer | 1,394 0.0064% | $14.23 | $19,837 | +2.6% | |
| 2025-12-05 | Sale | Enanta Pharmaceuticals, Inc. ENTA | Chief Scientific Officer | 2,390 0.0109% | $14.23 | $34,010 | +2.6% | |
| 2025-12-05 | Sale | Enanta Pharmaceuticals, Inc. ENTA | President and CEO | 4,743 0.0217% | $14.23 | $67,493 | +2.6% | |
| 2025-12-05 | Sale | Fennec Pharmaceuticals Inc. FENC | director | 10,000 0.0362% | $7.54 | $75,400 | +0.13% | |
| 2025-12-05 | Sale | Five9, Inc. FIVN | President | 700 0.0009% | $20.53 | $14,371 | +0.58% | |
| 2025-12-05 | Sale | Fabrinet FN | director | 500 0.0014% | $482.11 | $241,057 | -0.79% | |
| 2025-12-05 | Sale | IES Holdings, Inc. IESC | Executive Chairman | 3,774 0.0186% | $420.24 | $1.59M | +1.99% |